Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

BACKGROUND: Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pataky, Reka, Armstrong, Linlea, Chia, Stephen, Coldman, Andrew J, Kim-Sing, Charmaine, McGillivray, Barbara, Scott, Jenna, Wilson, Christine M, Peacock, Stuart
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711845/
https://ncbi.nlm.nih.gov/pubmed/23837641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-339
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars